Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
6
×
boston top stories
life sciences
national blog main
startups
6
×
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
clinical trials
deals
fda
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
national
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston
cancer
crispr therapeutics
epigenetics
ipo
mahesh karande
What
biotech
6
×
new
roundup
annual
attention
control
developing
drug
medicines
research
startup
therapeutics
today
according
ahead
aiming
aims
akcea
alzheimer’s
ambien
ambys
american
approach
asco
assessed
attendees
based
big
bio
called
camp’s
cancer
cases
cash
centers
chicago
cigarettes
city
clinical
combinations
Language
unset
Current search:
biotech
×
" boston blog main "
×
startups
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More